nasdaq listing - Robuta Search

https://finviz.com/news/325814/femasys-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. nasdaq listing announces inducement grants https://menafn.com/1111060342/Equillium-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). LA JOLLA, Calif., May 01, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a... nasdaq listing reports inducement grants https://finviz.com/news/345889/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Stock screener for investors and traders, financial visualizations. nasdaq listing cytokinetics announces inducement grants https://www.businesswire.com/news/home/20230707807146/en/Kezar-Announces-Inducement-Grant-Under-NASDAQ-Listing-Rule-5635c4 Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Kezar Life Sciences, Inc., (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and o... nasdaq listing kezar announces inducement grant https://www.biospace.com/columbia-laboratories-inc-regains-compliance-with-b-nasdaq-b-listing-standards-307872 Columbia Laboratories, Inc. Regains Compliance with NASDAQ Listing Standards - BioSpace compliance with nasdaq listing columbia laboratories inc https://www.businesswire.com/news/home/20250905376668/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurologic... nasdaq listing announces inducement grants https://www.financialcontent.com/article/bizwire-2025-3-21-evolus-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FinancialContent Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of... nasdaq listing https://www.newsfilecorp.com/release/288439/Optimi-Health-Announces-Proposed-Nasdaq-Listing-and-U.S.-Underwritten-Public-Offering Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company"... nasdaq listing https://investingnews.com/c4-therapeutics-announces-inducement-grant-under-nasdaq-listing-rule-5635/ C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635 | INN Jan 26, 2026 - C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today... nasdaq listing c4 therapeutics announces inducement https://www.ig.com/sg/news-and-trade-ideas/sezzle-s-share-price-rises-on-planned-nasdaq-listing-230315 Will Nasdaq listing boost Sezzle's share price? | IG SG Australian BNPL company Sezzle has seen its share price rise on plans to give US investors exposure with a listing on the Nasdaq Stock Exchange. nasdaq listing share price boost sezzle ig https://www.einpresswire.com/article/669864394/genedx-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nov 20, 2023 - GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that, effective as of November 17, 2023, the nasdaq listing genedx reports inducement grants https://www.businesswire.com/news/home/20201116005089/en/Forte-Biosciences-Inc.-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rules Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance of an equity inducement... nasdaq listing forte biosciences inc reports https://menafn.com/1109646708/Replimune-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). WOBURN, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ:... nasdaq listing announces inducement grants https://www.biospace.com/revance-reported-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Revance Reported Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - BioSpace Dec 21, 2020 - Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its investigational... nasdaq listing https://www.businesswire.com/news/home/20250808407224/en/Neurogene-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurologic... nasdaq listing announces inducement grants https://www.sandisk.com/company/newsroom/press-releases/2025/sandisk-celebrates-nasdaq-listing-after-completing-separation Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital | Sandisk Sandisk Corporation, a global Flash and advanced memory technology innovator, today announced that the company has completed its separation from Western... nasdaq listing sandisk celebrates completing separation https://finviz.com/news/341173/electrocore-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. nasdaq listing electrocore announces inducement grants https://finviz.com/news/338422/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Stock screener for investors and traders, financial visualizations. nasdaq listing cytokinetics announces inducement grants https://investingnews.com/nasdaq-listing-update/ NASDAQ Listing Update | INN Jan 9, 2024 - European Lithium Limited (ASX: EUR, FRA:PF8, OTC: EULIF) (European Lithium or the Company) advises that Sizzle Acquisition Corp, a publicly traded special... nasdaq listing update inn https://www.globenewswire.com/news-release/2025/07/18/3118168/0/en/Vor-Bio-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of... bio reports nasdaq listing vor inducement grant https://www.biospace.com/press-releases/mink-therapeutics-regains-full-compliance-with-nasdaq-listing-requirements MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements - BioSpace nasdaq listing requirements compliance with mink therapeutics regains https://www.digitaljournal.com/pr/news/accesswire/jaguar-health-requests-receives-hearing-1527883914.html Jaguar Health Requests and Receives Hearing on Nasdaq Listing Compliance health requests nasdaq listing jaguar receives hearing https://investingnews.com/adicet-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635/ Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635 | INN Sep 30, 2025 - Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune... bio reports nasdaq listing inducement grant https://www.engadget.com/2012-07-02-thq-retains-nasdaq-listing-as-board-approves-reverse-stock-split.html THQ retains NASDAQ listing as board approves reverse stock split Jul 2, 2012 - THQ will keep its NASDAQ listing following the approval of a reverse stock split by its controlling board. Last week, stockholders met and approved a 10-to-one... nasdaq listing thq retains board approves https://www.biospace.com/femasys-inc-regains-compliance-with-nasdaq-listing-requirements Femasys Inc. Regains Compliance with Nasdaq Listing Requirements - BioSpace Oct 12, 2023 - Femasys Inc. announced that it has it has received notice from The Nasdaq Stock Market LLC informing Femasys that it has regained compliance with the minimum... nasdaq listing requirements compliance with inc regains biospace https://www.itnews.com.au/news/softbank-mulls-nasdaq-listing-for-arm-581848 SoftBank mulls Nasdaq listing for Arm - iTnews CEO Masayoshi Son says no decision has been made. nasdaq listing softbank arm itnews https://www.sandisk.com/en-ua/company/newsroom/press-releases/2025/sandisk-celebrates-nasdaq-listing-after-completing-separation Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital | Sandisk Sandisk Corporation, a global Flash and advanced memory technology innovator, today announced that the company has completed its separation from Western... nasdaq listing sandisk celebrates completing separation https://finviz.com/news/340407/rapid7-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Rapid7 Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. nasdaq listing rapid7 reports inducement grants https://www.digitaljournal.com/pr/news/accesswire/oncocyte-regains-compliance-with-nasdaq-listing-requirements Oncocyte Regains Compliance With Nasdaq Listing Requirements compliance with nasdaq listing oncocyte regains requirements https://investingnews.com/surrozen-reports-inducement-grant-under-nasdaq-listing-rule-5635/ Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635 | INN Feb 24, 2026 - Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to... nasdaq listing reports inducement grant rule https://www.prnewswire.com/news-releases/nauticus-robotics-regains-compliance-with-nasdaq-listing-standards-302381871.html Nauticus Robotics Regains Compliance with Nasdaq Listing Standards /PRNewswire/ -- Nauticus Robotics, Inc. (NASDAQ: KITT), a leading innovator in autonomous subsea robotics and software, today announced that on February 18,... nauticus robotics compliance with nasdaq listing regains standards https://finviz.com/news/317045/aspire-biopharma-regains-full-compliance-with-nasdaq-listing-requirements Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements Stock screener for investors and traders, financial visualizations. compliance with nasdaq listing aspire biopharma regains https://investingnews.com/surrozen-reports-inducement-grants-under-nasdaq-listing-rule-5635/ Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635 | INN Sep 12, 2025 - Surrozen, Inc. ("Surrozen" or the "Company") (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt... nasdaq listing reports inducement grants rule https://investingnews.com/compass-announces-inducement-grants-under-nasdaq-listing-rule-5635/ Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635 | INN Jan 5, 2026 - Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to... nasdaq listing compass announces inducement grants https://menafn.com/1111068361/Absci-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635C4 Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4). VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation... nasdaq listing announces inducement grant https://www.businesswire.com/news/home/20260320045970/en/Evolus-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Evolus, Inc. (NASDAQ: EOLS) a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during ... nasdaq listing evolus reports inducement grants https://www.einpresswire.com/article/705082979/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Apr 19, 2024 - Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and nasdaq listing ultragenyx reports inducement grant https://www.sandisk.com/pt-br/company/newsroom/press-releases/2025/sandisk-celebrates-nasdaq-listing-after-completing-separation Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital | Sandisk Sandisk Corporation, a global Flash and advanced memory technology innovator, today announced that the company has completed its separation from Western... nasdaq listing sandisk celebrates completing separation https://www.globenewswire.com/news-release/2025/04/24/3067963/0/en/BIO-key-Regains-Compliance-with-Nasdaq-Listing-Rules-After-Receiving-Notice-of-Non-Compliance.html BIO-key Regains Compliance with Nasdaq Listing Rules After BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance for Delayed Form 10-K filing later filed Apr 23, 2025. ... compliance with nasdaq listing bio key regains https://www.globenewswire.com/news-release/2022/05/04/2436099/0/en/Sema4-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html Sema4 Reports Inducement Grants Under Nasdaq Listing Rule STAMFORD, Conn., May 04, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today... nasdaq listing reports inducement grants rule https://www.biospace.com/miragen-regains-compliance-with-nasdaq-listing-requirements miRagen Regains Compliance With Nasdaq Listing Requirements - BioSpace Jul 3, 2020 - miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today... nasdaq listing requirements compliance with miragen regains biospace https://www.biospace.com/press-releases/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4 Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - BioSpace nasdaq listing https://www.biospace.com/sarepta-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-777854 Sarepta Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - BioSpace nasdaq listing https://www.coinspeaker.com/nl/evernorth-xrp-treasury-op-weg-naar-nasdaq-claude-ai-verwacht-boost-voor-xrp-koers/ Evernorth XRP treasury klaar voor Nasdaq listing onder XRPN May 4, 2026 - Evernorth zet ruim 473 miljoen XRP in voor Nasdaq listing onder XRPN. Wat betekent dit voor de XRP koers verwachting? nasdaq listing evernorth xrp treasury klaar https://www.businesswire.com/news/home/20240516217789/en/Geron-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase... nasdaq listing geron reports inducement grants https://www.prnewswire.com/news-releases/delmar-pharmaceuticals-reports-full-compliance-with-nasdaq-listing-criteria-300913867.html DelMar Pharmaceuticals Reports Full Compliance with Nasdaq Listing Criteria /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of novel... compliance with nasdaq listing delmar pharmaceuticals reports https://www.pokernews.com/news/2015/06/pokerstars-launches-sports-betting-gets-ready-for-nasdaq-21752.htm PokerStars Launches Sports Betting, Gets Ready for Nasdaq Listing | PokerNews After months of speculation and announcements, PokerStars has finally decided to release its sports betting offering in the United Kingdom. sports betting ready for nasdaq listing pokerstars launches https://www.sandisk.com/zh-tw/company/newsroom/press-releases/2025/sandisk-celebrates-nasdaq-listing-after-completing-separation Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital | Sandisk Sandisk Corporation, a global Flash and advanced memory technology innovator, today announced that the company has completed its separation from Western... nasdaq listing sandisk celebrates completing separation https://www.prnewswire.com/news-releases/luokung-technology-corp-announces-updates-on-delay-to-listing-of-its-ordinary-shares-on-nasdaq-300716719.html Luokung Technology Corp. Announces Updates on Delay to Listing of Its Ordinary Shares on NASDAQ /PRNewswire/ -- Luokung Technology Corp. (Nasdaq: LKCO) ("LK" or the "Company"), a global leading graphics data processing technology company, a leading... https://www.biospace.com/press-releases/fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-july-11-2025 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 11, 2025... https://finviz.com/news/342264/fate-therapeutics-reports-new-employee-inducement-award-under-nasdaq-listing-rule-5635c4 Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://finviz.com/news/293261/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/karyopharm-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-july-05-2023 Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 05,... Jul 6, 2023 - Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Company granted an aggregate of... https://www.biospace.com/mirati-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-jan-06-2023 Mirati Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Jan 06, 2023 -... Jan 9, 2023 - Mirati Therapeutics, Inc., a clinical-stage targeted oncology company, announced that the company granted equity awards to 6 new employees with a grant date of... https://www.newsfilecorp.com/release/287693 Nicola Mining Provides Update on NASDAQ Listing Vancouver, British Columbia--(Newsfile Corp. - March 9, 2026) - Nicola Mining Inc. (TSXV: NIM) (OTCQB: HUSIF) (FSE: HLIA) (the "Company" or "Nicola")... nicola mining provides update nasdaq https://www.biospace.com/press-releases/x4-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-june-2-2025 X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 2, 2025... https://investingnews.com/cybin-to-transfer-u-s-stock-exchange-listing-to-nasdaq/ Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq | INN Dec 18, 2025 - Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) , a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by... u s stock exchange cybin transfer listing https://www.biospace.com/abeona-therapeutics-announces-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4-june-03-2024 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) -... Jun 4, 2024 - Abeona Therapeutics Inc. announced it has granted equity awards to new non-executive employees who joined the Company. https://www.biospace.com/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-12-2024 Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April... Apr 15, 2024 - Scholar Rock announced that the company granted inducement equity awards covering an aggregate of 45,000 shares of its common stock to two newly hired... https://www.prnewswire.com/news-releases/a-powers-stock-suspended-by-nasdaq-in-advance-of-nasdaq-listing-hearing-a-power-expects-common-stock-to-be-quoted-in-the-otc-pink-limited-tier-130571208.html A-Power's Stock Suspended by Nasdaq in Advance of Nasdaq Listing Hearing; A-Power Expects Common... /PRNewswire-Asia-FirstCall/ -- A-Power Energy Generation Systems, Ltd. (Nasdaq: APWR, "A-Power" or the "Company"), a leading provider of distributed power... https://www.finanznachrichten.de/nachrichten-2025-05/65444594-kimberly-clark-corporation-kimberly-clark-to-transfer-u-s-stock-exchange-listing-to-nasdaq-008.htm Kimberly-Clark Corporation: Kimberly-Clark to Transfer U.S. Stock Exchange Listing to Nasdaq Ticker symbol to remain "KMB" DALLAS, May 19, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB), a global leader in the consumer staples industry,... kimberly clark corporation u s stock exchange transfer https://www.biospace.com/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-march-04-2024 Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 04, 2024 -... Mar 5, 2024 - Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for... https://www.biospace.com/press-releases/twist-bioscience-corporation-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-may-13-2025 Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - May... https://menafn.com/1109646712/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis... https://www.biospace.com/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-02-2024 Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 02, 2024 -... Apr 3, 2024 - Cytokinetics, Incorporated announced that on March 29, 2024 it granted stock options to purchase an aggregate of 78,000 shares of common stock to five new... https://stockhouse.com/news/press-releases/2026/03/26/vivopower-receives-nasdaq-approval-of-ticker-temb-for-planned-tembo-listing-at-a 2026-03-26 | VivoPower Receives Nasdaq Approval of Ticker "TEMB" for Planned Tembo Listing at a... (2026-03-26 | EXPM:CCTSF) VivoPower Receives Nasdaq Approval of Ticker "TEMB" for Planned Tembo Listing at a Targeted Valuation of $838 Million https://www.biospace.com/paratek-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-dec-01-2021 Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Dec 01, 2021 - BioSpace Dec 2, 2021 - Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for... https://www.businesswire.com/news/home/20260331816781/en/Sarepta-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on March 31, 2026 that were previ... sarepta therapeutics https://www.businesswire.com/news/home/20240702778785/en/Astria-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4 Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, g... https://www.businesswire.com/news/home/20260313649739/en/Contineum-Therapeutics-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4 Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for th... https://www.prnewswire.com/news-releases/microsoft-to-transfer-listing-of-debt-securities-to-nasdaq-300947064.html Microsoft to transfer listing of debt securities to Nasdaq /PRNewswire/ -- Microsoft Corp. (NASDAQ: MSFT) on Tuesday announced it will be transferring the securities exchange listing for its Euro-denominated 2.125%... listing of debt securities microsoft transfer nasdaq https://www.biospace.com/press-releases/newamsterdam-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-february-7-2025 NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 7,... https://www.prnewswire.com/news-releases/1st-mariner-bancorp-announces-it-has-regained-compliance-with-nasdaq-global-market-listing-rules-83579222.html 1st Mariner Bancorp Announces It Has Regained Compliance With NASDAQ Global Market Listing Rules /PRNewswire-FirstCall/ -- 1st Mariner Bancorp (Nasdaq: FMAR) announced today that on February 3, 2010 it received a letter from The NASDAQ Stock Market... https://www.biospace.com/press-releases/iovance-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - BioSpace https://finviz.com/news/342373/syndax-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4 Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301186689.html PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 2, 2020 it approved non-statutory stock options to purchase an... ptc therapeutics https://www.businesswire.com/news/home/20250606336174/en/Gossamer-Bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4 Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the t... https://www.biospace.com/bellicum-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-april-30-2020 Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 30, 2020 - BioSpace May 1, 2020 - Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers, announced equity inducement grants to one new... https://www.barchart.com/story/news/289817/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635c4 Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) WAYNE, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing... https://www.biospace.com/press-releases/eyepoint-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-april-16-2025 EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 16,... https://www.biospace.com/press-releases/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635c4-june-19-2025 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - June 19, 2025 - BioSpace https://finviz.com/news/252641/aligos-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://finviz.com/news/340456/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/forte-biosciences-inc-reports-inducement-grant-under-nasdaq-listing-rules-december-01-2023 Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - December 01, 2023 -... Dec 4, 2023 - Forte Biosciences, Inc., a biopharmaceutical company focused on autoimmune diseases announced the issuance of an equity inducement award as required by the... https://menafn.com/1109874676/Akebia-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4 Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia... https://finviz.com/news/342963/madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://finviz.com/news/212901/ideaya-biosciences-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Stock screener for investors and traders, financial visualizations. https://www.biospace.com/press-releases/replimune-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-june-6-2025 Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025 - BioSpace